aluates Reports

$ 0.0

Automative

Global Small Interfering RNA (siRNA) Drugs Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-0T16519

Global Small Interfering RNA siRNA Drugs Market Research Report 2023

BUY CHAPTERS

Global Small Interfering RNA (siRNA) Drugs Market Research Report 2025

Code: QYRE-Auto-0T16519

Report

May 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam

Novartis

Sylentis

Arrowhead

Silence Therapeutics

Dicerna

Small Interfering RNA (siRNA) Drugs Market Size

The global market for Small Interfering RNA (siRNA) Drugs was valued at US$ 2047 million in the year 2024 and is projected to reach a revised size of US$ 10960 million by 2031, growing at a CAGR of 27.5% during the forecast period.

Small Interfering RNA (siRNA) Drugs Market

Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively "silencing" the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.

The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.

This report aims to provide a comprehensive presentation of the global market for Small Interfering RNA (siRNA) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Interfering RNA (siRNA) Drugs.

The Small Interfering RNA (siRNA) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Interfering RNA (siRNA) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Small Interfering RNA (siRNA) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Small Interfering RNA (siRNA) Drugs Market Report

Report Metric	Details
Report Name	Small Interfering RNA (siRNA) Drugs Market
Accounted market size in year	US$ 2047 million
Forecasted market size in 2031	US$ 10960 million
CAGR	27.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	GIVLAARI Onpattro OXLUMO AMVUTTRA Leqvio
Segment by Application	AHP hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam, Novartis, Sylentis, Arrowhead, Silence Therapeutics, Dicerna
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Small Interfering RNA (siRNA) Drugs Market growing?

Ans: The Small Interfering RNA (siRNA) Drugs Market witnessing a CAGR of 27.5% during the forecast period 2025-2031.

What is the Small Interfering RNA (siRNA) Drugs Market size in 2031?

Ans: The Small Interfering RNA (siRNA) Drugs Market size in 2031 will be US$ 10960 million.

Who are the main players in the Small Interfering RNA (siRNA) Drugs Market report?

Ans: The main players in the Small Interfering RNA (siRNA) Drugs Market are Alnylam, Novartis, Sylentis, Arrowhead, Silence Therapeutics, Dicerna

What are the Application segmentation covered in the Small Interfering RNA (siRNA) Drugs Market report?

Ans: The Applications covered in the Small Interfering RNA (siRNA) Drugs Market report are AHP, hATTR, Other

What are the Type segmentation covered in the Small Interfering RNA (siRNA) Drugs Market report?

Ans: The Types covered in the Small Interfering RNA (siRNA) Drugs Market report are GIVLAARI, Onpattro, OXLUMO, AMVUTTRA, Leqvio

Recommended Reports

RNA Therapeutics

Oligonucleotide Drugs

Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 GIVLAARI

1.2.3 Onpattro

1.2.4 OXLUMO

1.2.5 AMVUTTRA

1.2.6 Leqvio

1.3 Market by Application

1.3.1 Global Small Interfering RNA (siRNA) Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 AHP

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Interfering RNA (siRNA) Drugs Market Perspective (2020-2031)

2.2 Global Small Interfering RNA (siRNA) Drugs Growth Trends by Region

2.2.1 Global Small Interfering RNA (siRNA) Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Small Interfering RNA (siRNA) Drugs Historic Market Size by Region (2020-2025)

2.2.3 Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Region (2026-2031)

2.3 Small Interfering RNA (siRNA) Drugs Market Dynamics

2.3.1 Small Interfering RNA (siRNA) Drugs Industry Trends

2.3.2 Small Interfering RNA (siRNA) Drugs Market Drivers

2.3.3 Small Interfering RNA (siRNA) Drugs Market Challenges

2.3.4 Small Interfering RNA (siRNA) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Interfering RNA (siRNA) Drugs Players by Revenue

3.1.1 Global Top Small Interfering RNA (siRNA) Drugs Players by Revenue (2020-2025)

3.1.2 Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Small Interfering RNA (siRNA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Small Interfering RNA (siRNA) Drugs Revenue

3.4 Global Small Interfering RNA (siRNA) Drugs Market Concentration Ratio

3.4.1 Global Small Interfering RNA (siRNA) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Drugs Revenue in 2024

3.5 Global Key Players of Small Interfering RNA (siRNA) Drugs Head office and Area Served

3.6 Global Key Players of Small Interfering RNA (siRNA) Drugs, Product and Application

3.7 Global Key Players of Small Interfering RNA (siRNA) Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Interfering RNA (siRNA) Drugs Breakdown Data by Type

4.1 Global Small Interfering RNA (siRNA) Drugs Historic Market Size by Type (2020-2025)

4.2 Global Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Type (2026-2031)

5 Small Interfering RNA (siRNA) Drugs Breakdown Data by Application

5.1 Global Small Interfering RNA (siRNA) Drugs Historic Market Size by Application (2020-2025)

5.2 Global Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Small Interfering RNA (siRNA) Drugs Market Size (2020-2031)

6.2 North America Small Interfering RNA (siRNA) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025)

6.4 North America Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Interfering RNA (siRNA) Drugs Market Size (2020-2031)

7.2 Europe Small Interfering RNA (siRNA) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025)

7.4 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size (2020-2031)

8.2 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Small Interfering RNA (siRNA) Drugs Market Size (2020-2031)

9.2 Latin America Small Interfering RNA (siRNA) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025)

9.4 Latin America Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size (2020-2031)

10.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam

11.1.1 Alnylam Company Details

11.1.2 Alnylam Business Overview

11.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Introduction

11.1.4 Alnylam Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.1.5 Alnylam Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Small Interfering RNA (siRNA) Drugs Introduction

11.2.4 Novartis Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Sylentis

11.3.1 Sylentis Company Details

11.3.2 Sylentis Business Overview

11.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Introduction

11.3.4 Sylentis Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.3.5 Sylentis Recent Development

11.4 Arrowhead

11.4.1 Arrowhead Company Details

11.4.2 Arrowhead Business Overview

11.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Introduction

11.4.4 Arrowhead Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.4.5 Arrowhead Recent Development

11.5 Silence Therapeutics

11.5.1 Silence Therapeutics Company Details

11.5.2 Silence Therapeutics Business Overview

11.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Introduction

11.5.4 Silence Therapeutics Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.5.5 Silence Therapeutics Recent Development

11.6 Dicerna

11.6.1 Dicerna Company Details

11.6.2 Dicerna Business Overview

11.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Introduction

11.6.4 Dicerna Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

11.6.5 Dicerna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam

Novartis

Sylentis

Arrowhead

Silence Therapeutics

Dicerna

List of Tables

Table 1. Global Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of GIVLAARI

Table 3. Key Players of Onpattro

Table 4. Key Players of OXLUMO

Table 5. Key Players of AMVUTTRA

Table 6. Key Players of Leqvio

Table 7. Global Small Interfering RNA (siRNA) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Small Interfering RNA (siRNA) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Small Interfering RNA (siRNA) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Small Interfering RNA (siRNA) Drugs Market Share by Region (2020-2025)

Table 11. Global Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Small Interfering RNA (siRNA) Drugs Market Share by Region (2026-2031)

Table 13. Small Interfering RNA (siRNA) Drugs Market Trends

Table 14. Small Interfering RNA (siRNA) Drugs Market Drivers

Table 15. Small Interfering RNA (siRNA) Drugs Market Challenges

Table 16. Small Interfering RNA (siRNA) Drugs Market Restraints

Table 17. Global Small Interfering RNA (siRNA) Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Small Interfering RNA (siRNA) Drugs Market Share by Players (2020-2025)

Table 19. Global Top Small Interfering RNA (siRNA) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Drugs as of 2024)

Table 20. Ranking of Global Top Small Interfering RNA (siRNA) Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Small Interfering RNA (siRNA) Drugs, Headquarters and Area Served

Table 23. Global Key Players of Small Interfering RNA (siRNA) Drugs, Product and Application

Table 24. Global Key Players of Small Interfering RNA (siRNA) Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Small Interfering RNA (siRNA) Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Small Interfering RNA (siRNA) Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Small Interfering RNA (siRNA) Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. Alnylam Company Details

Table 50. Alnylam Business Overview

Table 51. Alnylam Small Interfering RNA (siRNA) Drugs Product

Table 52. Alnylam Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 53. Alnylam Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Small Interfering RNA (siRNA) Drugs Product

Table 57. Novartis Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Sylentis Company Details

Table 60. Sylentis Business Overview

Table 61. Sylentis Small Interfering RNA (siRNA) Drugs Product

Table 62. Sylentis Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 63. Sylentis Recent Development

Table 64. Arrowhead Company Details

Table 65. Arrowhead Business Overview

Table 66. Arrowhead Small Interfering RNA (siRNA) Drugs Product

Table 67. Arrowhead Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 68. Arrowhead Recent Development

Table 69. Silence Therapeutics Company Details

Table 70. Silence Therapeutics Business Overview

Table 71. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product

Table 72. Silence Therapeutics Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 73. Silence Therapeutics Recent Development

Table 74. Dicerna Company Details

Table 75. Dicerna Business Overview

Table 76. Dicerna Small Interfering RNA (siRNA) Drugs Product

Table 77. Dicerna Revenue in Small Interfering RNA (siRNA) Drugs Business (2020-2025) & (US$ Million)

Table 78. Dicerna Recent Development

Table 79. Research Programs/Design for This Report

Table 80. Key Data Information from Secondary Sources

Table 81. Key Data Information from Primary Sources

Table 82. Authors List of This Report

List of Figures

Figure 1. Small Interfering RNA (siRNA) Drugs Picture

Figure 2. Global Small Interfering RNA (siRNA) Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Small Interfering RNA (siRNA) Drugs Market Share by Type: 2024 VS 2031

Figure 4. GIVLAARI Features

Figure 5. Onpattro Features

Figure 6. OXLUMO Features

Figure 7. AMVUTTRA Features

Figure 8. Leqvio Features

Figure 9. Global Small Interfering RNA (siRNA) Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Small Interfering RNA (siRNA) Drugs Market Share by Application: 2024 VS 2031

Figure 11. AHP Case Studies

Figure 12. hATTR Case Studies

Figure 13. Other Case Studies

Figure 14. Small Interfering RNA (siRNA) Drugs Report Years Considered

Figure 15. Global Small Interfering RNA (siRNA) Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Small Interfering RNA (siRNA) Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Small Interfering RNA (siRNA) Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Small Interfering RNA (siRNA) Drugs Market Share by Players in 2024

Figure 19. Global Top Small Interfering RNA (siRNA) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Drugs Revenue in 2024

Figure 21. North America Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Small Interfering RNA (siRNA) Drugs Market Share by Country (2020-2031)

Figure 23. United States Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Small Interfering RNA (siRNA) Drugs Market Share by Country (2020-2031)

Figure 27. Germany Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Share by Region (2020-2031)

Figure 35. China Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Small Interfering RNA (siRNA) Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Small Interfering RNA (siRNA) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Alnylam Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 52. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 53. Arrowhead Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 54. Silence Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 55. Dicerna Revenue Growth Rate in Small Interfering RNA (siRNA) Drugs Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA Therapeutics Market Insights Forecast to 2030

Global RNAi Therapeutics Market Research Report 2024

Global Nucleic Acid Drugs Market Research Report 2025

Global RNA Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA Market Research Report 2024

Global Small Nucleic Acid Drug Market Research Report 2025

Global RNA based Therapeutics Drug Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

Global Vector Based RNAi Market Research Report 2024

Global Nucleic Acid based Therapy Market Research Report 2024

Global Nucleic Acid Therapeutic Market Research Report 2024

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Global siRNA Drug Market Research Report 2024

Global Nucleic Acid Medicine Market Research Report 2025

Global Oligonucleotide Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions